Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00ORM
|
|||
Former ID |
DNC005041
|
|||
Drug Name |
5-Carbazol-9-yl-pentanoic acid
|
|||
Synonyms |
CHEMBL184795; 5-Carbazol-9-yl-pentanoic acid; SCHEMBL12951764; BDBM50152858
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H17NO2
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C3=CC=CC=C3N2CCCCC(=O)O
|
|||
InChI |
1S/C17H17NO2/c19-17(20)11-5-6-12-18-15-9-3-1-7-13(15)14-8-2-4-10-16(14)18/h1-4,7-10H,5-6,11-12H2,(H,19,20)
|
|||
InChIKey |
YEPJVQJMLQBLOE-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid-binding protein 4 (FABP4) | Target Info | Inhibitor | [1] |
Fatty acid-binding protein 5 (FABP5) | Target Info | Inhibitor | [1] | |
KEGG Pathway | PPAR signaling pathway | |||
NetPath Pathway | IL1 Signaling Pathway | |||
TCR Signaling Pathway | ||||
Pathway Interaction Database | AP-1 transcription factor network | |||
Reactome | Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |||
Transcriptional regulation of white adipocyte differentiation | ||||
WikiPathways | Lipid digestion, mobilization, and transport | |||
Transcriptional Regulation of White Adipocyte Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.